ClinConnect ClinConnect Logo
Search / Trial NCT06304428

Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications

Launched by DUKE UNIVERSITY · Mar 8, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Osteoporosis Deprescribing Falls Skilled Nursing Facilities

ClinConnect Summary

After hospitalization for fracture, approximately 60% of older adults receive post-acute care in Skilled Nursing Facilities (SNFs), but fewer than 20% of these individuals receive medication optimization, which is evidence-based care known to prevent additional injurious falls, fractures, and mortality. Therefore, there is an opportunity to substantially improve care and patient outcomes in this setting. The purpose of this study is to determine the comparative efficacy of a Deprescribing Care Model designed to deprescribe fall related medications (FRIDs), a Bone Heath Service Model designe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 65 years or greater
  • Admitted to an enrolled SNF after hospitalized fracture
  • Completion of a medication optimization plan
  • Exclusion Criteria:
  • Non-osteoporotic fracture (e.g. facial, digital, skull, at site of tumor or infection)
  • Eligible for Hospice or palliative care
  • Patient discharged or died prior to completion of a medication optimization plan

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Durham, North Carolina, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Cathleen S Colon-Emeric, MD, MHS

Principal Investigator

Duke University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported